Illumina addresses recent developments in China
Portfolio Pulse from
Illumina, Inc. announced it will not be able to export sequencing instruments to China following a decision by the China Ministry of Commerce. Despite this, the company projects a Fiscal Year 2025 Non-GAAP Diluted EPS of approximately $4.50.
March 10, 2025 | 8:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Illumina cannot export sequencing instruments to China due to a decision by MOFCOM. Despite this, the company projects a FY 2025 EPS of $4.50.
The inability to export to China could negatively impact Illumina's revenue from one of the largest markets for sequencing instruments. However, the company's projection of a $4.50 EPS for FY 2025 suggests confidence in other revenue streams or cost management, partially offsetting the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100